3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Venous Thromboembolism
1
Urologic Neoplasms
1
Urogenital Neoplasms
1
Thrombosis
1
Thromboembolism
1
Prostatic Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Inflammation
1
Immune System Diseases
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
pembrolizumab
27
Docetaxel
20
Cyclophosphamide
18
Surveys and Questionnaires
15
Therapeutics
14
Radiotherapy
13
Paclitaxel
12
Psychiatric Rehabilitation
11
Early Intervention, Educational
11
Carboplatin
11
Standard of Care
10
olaparib
9
Zoledronic Acid
9
Specimen Handling
9
Radiosurgery
9
Magnetic Resonance Spectroscopy
9
Interviews as Topic
9
Gemcitabine
9
Trastuzumab
8
Methods
8
Fulvestrant
8
palbociclib
7
fludarabine
7
durvalumab
7
Taxes
7
Nivolumab
7
Fluorodeoxyglucose F18
7
Flow Cytometry
7
Educational Status
7
Blood Specimen Collection
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Rivaroxaban
×
Genitourinary
×
Clear all
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled